http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2011093483-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 |
| filingDate | 2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2011093483-A1 |
| titleOfInvention | Hepatitis C therapeutic agent |
| abstract | Provided is a therapeutic agent for hepatitis C, comprising a compound having anti-HCV activity useful for the treatment of hepatitis C as an active ingredient. Formula (I): The therapeutic agent for hepatitis C which uses the compound represented by these, or its pharmaceutically acceptable salt as an active ingredient. |
| priorityDate | 2010-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 594.